BG
SRNE

BlackRock Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

BlackRock Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q4 		$37K Buy
+7,477
New +$37K ﹤0.01% 2923
2014
Q2 		– Sell
-17,439
Closed -$223K – 2846
2014
Q1 		$223K Buy
+17,439
New +$223K ﹤0.01% 2421